{"SLR NAME":"The possibility and cause of relapse after previously recovered from COVID-19: a systematic review","References":[{"title1":"Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","References":[{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"},{"title3":"Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan,%20China:%20a%20descriptive%20study"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"}]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","References":[{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"},{"title3":"Detection%20of%202019%20novel%20coronavirus%20(2019-nCoV)%20by%20real-time%20RT-PCR"}]},{"title2":"WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. https://wwwwhoint/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 (Accessed 4 February 2020). 2020.","References":[]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"}]},{"title2":"Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression","References":[]}]},{"title1":"Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020","References":[{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia.","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia."}]},{"title2":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.","References":[{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20The%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China."},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20The%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China."},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20The%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China."},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20The%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China."},{"title3":"The%20continuing%202019-nCoV%20epidemic%20threat%20of%20novel%20coronaviruses%20to%20global%20health%20-%20The%20latest%202019%20novel%20coronavirus%20outbreak%20in%20Wuhan,%20China."}]},{"title2":"World Health Organization (WHO). World experts and funders set priorities for COVID-19 research. Geneva: WHO; 12 Feb 2020. Available from: https://www.who.int/news-room/detail/12-02-2020-world-experts-and-funders-set-priorities-for-covid-19-research ","References":[]},{"title2":"National Health Commission of the People's Republic of China. Update on the epidemic situation of the novel coronavirus pneumonia as at 24:00 on 4 Mar 2020. Beijing: National Health Commission of the People's Republic of China; 4 Mar 2020. Chinese. Available from: http://www.nhc.gov.cn/xcs/yqfkdt/202003/6e02433f7786402d8ea162fb5b80b5a0.shtml ","References":[]},{"title2":"National Institute for Viral Disease Control and Prevention (China). Specific primers and probes for detection 2019 novel coronavirus. Beijing: National Institute for Viral Disease Control and Prevention (China); 21 Jan 2020.Chinese. Available from: http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html ","References":[]},{"title2":"National Health Commission of the People's Republic of China. Diagnosis and treatment protocols of the novel coronavirus pneumonia (trial version 6). Beijing: National Health Commission of the People's Republic of China; 19 Feb 2020.Chinese. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf ","References":[]},{"title2":"China Daily Website. Recovered patient re-hospitalized after positive test. Beijing: China Daily Website; 21 Feb 2020. Chinese. Available from: http://ex.chinadaily.com.cn/exchange/partners/45/rss/channel/www/columns/2n8e04/stories/WS5e4fc442a31012821727963c.html ","References":[]},{"title2":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.","References":[{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes."}]},{"title2":"Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR.","References":[{"title3":"Sensitivity%20of%20Chest%20CT%20for%20COVID-19:%20Comparison%20to%20RT-PCR."},{"title3":"Sensitivity%20of%20Chest%20CT%20for%20COVID-19:%20Comparison%20to%20RT-PCR."},{"title3":"Sensitivity%20of%20Chest%20CT%20for%20COVID-19:%20Comparison%20to%20RT-PCR."},{"title3":"Sensitivity%20of%20Chest%20CT%20for%20COVID-19:%20Comparison%20to%20RT-PCR."}]},{"title2":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing.","References":[]},{"title2":"National Health Commission of Changde (China). Update on the epidemic situation of the novel coronavirus pneumonia in Changde on 10 Feb 2020. Changde: National Health Commission of Changde (China); 10 Feb 2020. Chinese. Available from: http://wjw.changde.gov.cn/zhdt/wjdt/content_718989 ","References":[]}]},{"title1":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","References":[{"title2":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","References":[{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"},{"title3":"A%20familial%20cluster%20of%20pneumonia%20associated%20with%20the%202019%20novel%20coronavirus%20indicating%20person-to-person%20transmission:%20a%20study%20of%20a%20family%20cluster"}]},{"title2":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","References":[]},{"title2":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection","References":[]},{"title2":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","References":[{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"},{"title3":"Clinical%20progression%20and%20viral%20load%20in%20a%20community%20outbreak%20of%20coronavirus-associated%20SARS%20pneumonia:%20a%20prospective%20study"}]},{"title2":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings","References":[]},{"title2":"Consistent detection of 2019 novel coronavirus in saliva","References":[]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","References":[{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"},{"title3":"SARS-CoV-2%20viral%20load%20in%20upper%20respiratory%20specimens%20of%20infected%20patients"}]},{"title2":"Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study","References":[]},{"title2":"Respiratory virus infection among hospitalized adult patients with or without clinically apparent respiratory infection: a prospective cohort study","References":[]},{"title2":"Additional molecular testing of saliva specimens improves the detection of respiratory viruses","References":[{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"},{"title3":"Additional%20molecular%20testing%20of%20saliva%20specimens%20improves%20the%20detection%20of%20respiratory%20viruses"}]},{"title2":"Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens","References":[]},{"title2":"Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia","References":[{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"},{"title3":"Relative%20rates%20of%20non-pneumonic%20SARS%20coronavirus%20infection%20and%20SARS%20coronavirus%20pneumonia"}]},{"title2":"Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains","References":[{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"},{"title3":"Assessment%20of%20population%20susceptibility%20to%20upcoming%20seasonal%20influenza%20epidemic%20strain%20using%20interepidemic%20emerging%20influenza%20virus%20strains"}]},{"title2":"Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63","References":[]},{"title2":"Viral load kinetics of MERS coronavirus infection","References":[]},{"title2":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb/III trial","References":[]},{"title2":"Treatment With lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","References":[{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"},{"title3":"Treatment%20With%20lopinavir/ritonavir%20or%20interferon-beta1b%20improves%20outcome%20of%20MERS-CoV%20infection%20in%20a%20nonhuman%20primate%20model%20of%20common%20marmoset"}]},{"title2":"Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors","References":[{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"},{"title3":"Molecular%20dynamic%20simulations%20analysis%20of%20ritonavir%20and%20lopinavir%20as%20SARS-CoV%203CL(pro)%20inhibitors"}]},{"title2":"Initial viral load and the outcomes of SARS","References":[]},{"title2":"Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms","References":[]},{"title2":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","References":[{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"},{"title3":"Molecular%20and%20serological%20investigation%20of%202019-nCoV%20infected%20patients:%20implication%20of%20multiple%20shedding%20routes"}]},{"title2":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals","References":[{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"},{"title3":"Antibody%20responses%20against%20SARS%20coronavirus%20are%20correlated%20with%20disease%20outcome%20of%20infected%20individuals"}]},{"title2":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","References":[]},{"title2":"Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus","References":[{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Analysis%20of%20intrapatient%20heterogeneity%20uncovers%20the%20microevolution%20of%20Middle%20East%20respiratory%20syndrome%20coronavirus"}]},{"title2":"Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis","References":[{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"},{"title3":"Detection%20of%20SARS-associated%20coronavirus%20in%20throat%20wash%20and%20saliva%20in%20early%20diagnosis"}]},{"title2":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"},{"title3":"Clinical%20characteristics%20of%20coronavirus%20disease%202019%20in%20China"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"},{"title3":"Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus:%20implications%20for%20virus%20origins%20and%20receptor%20binding"}]},{"title2":"Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43","References":[]}]},{"title1":"Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients","References":[{"title2":"New SARS-like virus in China triggers alarm","References":[]},{"title2":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","References":[{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"},{"title3":"Cryo-EM%20structure%20of%20the%202019-nCoV%20spike%20in%20the%20prefusion%20conformation"}]},{"title2":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","References":[]},{"title2":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","References":[{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"},{"title3":"Functional%20assessment%20of%20cell%20entry%20and%20receptor%20usage%20for%20SARS-CoV-2%20and%20other%20lineage%20B%20betacoronaviruses"}]},{"title2":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","References":[{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"},{"title3":"SARS-CoV-2%20Cell%20Entry%20Depends%20on%20ACE2%20and%20TMPRSS2%20and%20Is%20Blocked%20by%20a%20Clinically%20Proven%20Protease%20Inhibitor"}]},{"title2":"Lv, H. et al. Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. In press. 10.1016/j.celrep.2020.107725 (2020).","References":[]},{"title2":"Wu, F. et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. Available at SSRN: 10.2139/ssrn.3566211 (2020).","References":[]},{"title2":"A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2","References":[{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"},{"title3":"A%20Sequence%20Homology%20and%20Bioinformatic%20Approach%20Can%20Predict%20Candidate%20Targets%20for%20Immune%20Responses%20to%20SARS-CoV-2"}]},{"title2":"Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV","References":[{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"},{"title3":"Novel%20antibody%20epitopes%20dominate%20the%20antigenicity%20of%20spike%20glycoprotein%20in%20SARS-CoV-2%20compared%20to%20SARS-CoV"}]},{"title2":"Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies","References":[{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"},{"title3":"Preliminary%20Identification%20of%20Potential%20Vaccine%20Targets%20for%20the%20COVID-19%20Coronavirus%20(SARS-CoV-2)%20Based%20on%20SARS-CoV%20Immunological%20Studies"}]},{"title2":"Wang, H. et al. SARS-CoV-2 proteome microarray for mapping COVID-19 antibody interactions at amino acid resolution. Preprint at: https://doi.org/10.1101/2020.03.26.994756 (2020).","References":[]},{"title2":"Characterisation of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide","References":[]},{"title2":"Fusion peptide in the spike protein of MERS coronavirus","References":[{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"},{"title3":"Fusion%20peptide%20in%20the%20spike%20protein%20of%20MERS%20coronavirus"}]},{"title2":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","References":[{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"},{"title3":"Potent%20binding%20of%202019%20novel%20coronavirus%20spike%20protein%20by%20a%20SARS%20coronavirus-specific%20human%20monoclonal%20antibody"}]},{"title2":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","References":[{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"},{"title3":"A%20pan-coronavirus%20fusion%20inhibitor%20targeting%20the%20HR1%20domain%20of%20human%20coronavirus%20spike"}]},{"title2":"The 2019 novel coronavirus resource","References":[{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"},{"title3":"The%202019%20novel%20coronavirus%20resource"}]},{"title2":"Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products","References":[{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"},{"title3":"Evaluation%20of%20inactivation%20methods%20for%20severe%20acute%20respiratory%20syndrome%20coronavirus%20in%20noncellular%20blood%20products"}]},{"title2":"Novel differential linear B-cell epitopes to identify Zika and dengue virus infections in patients","References":[]},{"title2":"Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein","References":[{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"},{"title3":"Early%20neutralizing%20IgG%20response%20to%20Chikungunya%20virus%20in%20infected%20patients%20targets%20a%20dominant%20linear%20epitope%20on%20the%20E2%20glycoprotein"}]},{"title2":"Type I interferon shapes the quantity and quality of the anti-Zika virus antibody response","References":[{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"},{"title3":"Type%20I%20interferon%20shapes%20the%20quantity%20and%20quality%20of%20the%20anti-Zika%20virus%20antibody%20response"}]},{"title2":"Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus","References":[]},{"title2":"Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody","References":[{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"},{"title3":"Substitution%20at%20aspartic%20acid%201128%20in%20the%20SARS%20coronavirus%20spike%20glycoprotein%20mediates%20escape%20from%20a%20S2%20domain-targeting%20neutralizing%20monoclonal%20antibody"}]},{"title2":"Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore","References":[]}]},{"title1":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"},{"title3":"Clinical%20features%20of%20patients%20infected%20with%202019%20novel%20coronavirus%20in%20Wuhan,%20China"}]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"},{"title3":"A%20novel%20coronavirus%20from%20patients%20with%20pneumonia%20in%20China,%202019"}]},{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"},{"title3":"Early%20transmission%20dynamics%20in%20Wuhan,%20China,%20of%20novel%20coronavirus-infected%20pneumonia"}]},{"title2":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin","References":[]},{"title2":"Serological evidence of bat SARS-related coronavirus infection in humans, China","References":[{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"},{"title3":"Serological%20evidence%20of%20bat%20SARS-related%20coronavirus%20infection%20in%20humans,%20China"}]},{"title2":"Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases","References":[]},{"title2":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","References":[{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"},{"title3":"Organ%20distribution%20of%20severe%20acute%20respiratory%20syndrome%20(SARS)%20associated%20coronavirus%20(SARS-CoV)%20in%20SARS%20patients:%20implications%20for%20pathogenesis%20and%20virus%20transmission%20pathways"}]},{"title2":"Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus","References":[{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"},{"title3":"Human%20intestinal%20tract%20serves%20as%20an%20alternative%20infection%20route%20for%20Middle%20East%20respiratory%20syndrome%20coronavirus"}]}]}]}